This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitetet I Oslo. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Andrej Besse: Innovator in Cancer Treatment
Introduction
Andrej Besse is a notable inventor based in St. Gallen, Switzerland. He has made significant contributions to the field of cancer treatment, particularly through his innovative research on ALK inhibitors. His work focuses on addressing ALK-negative cancers and plasma cell-mediated diseases, which are critical areas in oncology.
Latest Patents
Andrej Besse holds 1 patent for his invention titled "ALK inhibitors for treatment of ALK-negative cancer and plasma cell-mediated diseases." This patent presents a method for treating ALK-negative/LTK-positive cancer by administering a pharmaceutically effective dose of a linear inhibitor of ALK. The invention is particularly useful in treating multiple myeloma, including cases that are resistant to proteasome inhibitors.
Career Highlights
Andrej Besse is affiliated with the University of Oslo, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from challenging forms of cancer.
Collaborations
Andrej collaborates with esteemed colleagues such as Hesso Farhan and Ludvig Munthe. Their combined expertise contributes to the innovative research environment at the University of Oslo.
Conclusion
Andrej Besse's contributions to cancer treatment through his patented inventions highlight the importance of innovation in medical research. His work not only addresses significant health challenges but also paves the way for future advancements in oncology.